Activation of invariant NKT cells by αGalCer administration protects mice from MOG35-55-induced EAE: Critical roles for administration route and IFN-γ

European Journal of Immunology

Volumn 33, Issue 7, 2003, Pages 1830-1838

  Furlan, Roberto ^a   Bergami, Alessandra ^a   Cantarella, Daniela ^a   Brambilla, Elena ^a   Taniguchi, Masaro ^b   Dellabona, Paolo ^a   Casorati, Giulia ^a   Martino, Gianvito ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Autoimmunity; EAE; MS; Neuroimmunology; T lymphocyte

Indexed keywords

CD1D ANTIGEN; CYTOKINE; ENCEPHALITOGENIC PROTEIN; FREUND ADJUVANT; GALACTOSYLCERAMIDE; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; GLYCOSPHINGOLIPID; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; ALPHA GALACTOSIDASE; GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35 55); MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE FRAGMENT;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEMYELINATION; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; FEMALE; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; ANIMAL; C57BL MOUSE; IMMUNOLOGY; LYMPH NODE; METABOLISM;

ALPHA-GALACTOSIDASE; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GLYCOPROTEINS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LYMPH NODES; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

EID: 0041968838     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323885     Document Type: Article

References (40)

1. Bendelac, A., Rivera, M. N., Park, S. H. and Roark, J. H., Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 1997. 15: 535-562.
2. Dellabona, P., Padovan, E., Casorati, G., Brockhaus, M. and Lanzavecchia, A., An invariant Vα24-JαQ/Vβ11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J. Exp. Med. 1994. 180: 1171-1176.
3. Koseki, H., Asano, H., Inaba, T., Miyashita, N., Moriwaki, K., Lindahl, K. F., Mizutani, Y., Imai, K. and Taniguchi, M., Dominant expression of a distinctive V14+ T cell antigen receptor alpha chain in mice. Proc. Natl. Acad. Sci. U S A 1991. 88: 7518-7522.
4. Lantz, O. and Bendelac, A., An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J. Exp. Med. 1994. 180: 1097-1106.
5. Bendelac, A., Lantz, O., Quimby, M. E., Yewdell, J. W., Bennink, J. R. and Brutkiewicz, R. R., CD1 recognition by mouse NK1+ T lymphocytes. Science 1995. 268: 863-865.
6. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H. and Taniguchi, M., CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997. 278: 1626-1629.
7. Brossay, L., Chioda, M., Burdin, N., Koezuka, Y., Casorati, G., Dellabona, P. and Kronenberg, M., CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 1998. 188: 1521-1528.
8. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J. and Baxter, A. G., NKT cells: facts, functions and fallacies. Immunol. Today 2000. 21: 573-583.
9. Singh, N., Hong, S., Scherer, D. C., Serizawa, I., Burdin, N., Kronenberg, M., Koezuka, Y. and Van Kaer, L., Cutting edge: activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 1999. 163: 2373-2377.
10. Burdin, N., Brossay, L. and Kronenberg, M., Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 1999. 29: 2014-2025.
11. Cui, J., Watanabe, N., Kawano, T., Yamashita, M., Kamata, T., Shimizu, C., Kimura, M., Shimizu, E., Koike, J., Koseki, H., Tanaka, Y., Taniguchi, M. and Nakayama, T., Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells. J. Exp. Med. 1999. 190: 783-792.
12. Tomura, M., Yu, W. G., Ahn, H. J., Yamashita, M., Yang, Y. F., Ono, S., Hamaoka, T., Kawano, T., Taniguchi, M., Koezuka, Y. and Fujiwara, H., A novel function of Vα14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 1999. 163: 93-101.
13. Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T., Haba, T., Scherer, D. C., Wei, J., Kronenberg, M., Koezuka, Y. and Van Kaer, L., The natural killer T cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001. 7: 1052-1056.
14. Sharif, S., Arreaza, G. A., Zucker, P. et al., Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 2001. 7: 1057-1062.
15. Hemmer, B., Archelos, J. J. and Hartung, H. P., New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 2002. 3: 291-301.
16. Kieseier, B., Storch, M. K., Archelos, J. J., Martino, G., and Hartung, H. P., Effector pathways in immune mediated central nervous system demyelination. Curr. Opin. Neurol. 1999. 12: 323-336.
17. Martino, G. and Hartung, H. P., Immunopathogenesis of multiple sclerosis: the role of T cells. Curr. Opin. Neurol. 1999. 12: 309-321.
18. Pearson, C. I. and MacDevitt, H. O., Redirecting Th1 and Th2 responses in autoimmune disease. Curr. Top. Microbiol. Immunol 1999. 238: 79-122.
19. Pal, E., Tabira, T., Kawano, T., Taniguchi, M., Miyake, S. and Yamamura, T., Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells. J. Immunol. 2001. 166: 662-668.
20. Miyamoto, K., Miyake, S. and Yamamura, T., A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001. 413: 531-534.
21. Jahng, A. W., Maricic, I., Pedersen, B., Burdin, N., Naidenko, O., Kronenberg, M., Koezuka, Y. and Kumar, V., Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 2001. 194: 1789-1799.
22. Singh, A. K., Wilson M. T., Hong, S., Olivares-Villagomez, D., Du, C., Stanic, A. K., Joyce, S., Sriram, S., Koezuka, Y. and Van Kaer, L., Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 2001. 194: 1801-1811.
23. Sumida, T., Sakamoto, A., Murata, H., Makino, Y., Takahashi, H., Yoshida, S., Nishioka, K., Iwamoto, I. and Taniguchi, M., Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J. Exp. Med. 1995. 182: 1163-1168.
24. Wilson, S. B., Kent, S. C., Patton, K. T., Orban, T., Jackson, R. A., Exley, M., Porcelli, S., Schatz, D. A., Atkinson, M. A., Balk, S. P., Strominger, J. L. and Hafler, D. A., Extreme Th1 bias of invariant Vα24 JαQ T cells in type 1 diabetes. Nature 1998. 391: 177-181.
25. Maeda, T., Keino, H., Asahara, H., Taniguchi, M., Nishioka, K. and Sumida, K., Decreased TCR αV24αJ18+ double-negative T cells in rheumatoid synovium. Rheumatology 1999. 38: 186-188.
26. Falcone, M., Yeung, B., Tucker, L., Rodriguez, E. and Sarvetnick, N., A defect in interleukin 12-induced activation and interferon γ secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J. Exp. Med. 1999. 190: 963-972.
27. Hammond, K. J. L., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I. and Baxter, A. G., α/β-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 1998. 187: 1047-1056.
28. Lehuen, A., Lantz, O., Beaudoin, L., Laloux, V., Carnaud, C., Bendelac, A., Bach, J. F. and Monteiro, R. C., Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 1998. 188: 1831-1839.
29. Mars, L. T., Laloux, V., Goude, K., Desbois, S., Saoudi, A., Van Kaer, L., Lassmann, H., Herbelin, A., Lehuen, A. and Liblau, R. S., Vα14-Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J. Immunol. 2002. 168: 6007-6011.
30. + T cells. J. Immunol. 2001. 166: 4209-4215.
31. Billiau, A., Heremans, H., Vandekerckhove, F., Dijkmans, R., Sobis, H., Meulepas, E. and Carton, H., Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ. J. Immunol. 1988. 140: 1506-1510.
32. Furlan, R., Brambilla, E., Ruffini, F., Poliani, P. L., Bergami, A., Marconi, P. C., Franciotta, D. M., Penna, G., Comi, G., Adorini, L. and Martino, G., Intrathecal delivery of IFN-γ protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J. Immunol. 2001. 1670: 1821-1829.
33. Matthys, P., Vermeire, K. and Billiau, A., Mac-1(+) myelopoiesis induced by CFA: a clue to the paradoxical effects of IFN-γ in autoimmune disease models. Trends. Immunol. 2001. 22: 367-371.
34. Legge, K. L., Min, B., Bell, J. J., Caprio, J. C., Li, L., Gregg, R. K. and Zaghouani, H., Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis. J. Exp. Med. 2000. 191: 2039-2052.
35. Allione, A., Bernabei, P., Bosticardo, M., Ariotti, S., Forni, G., and Novelli, F., Nitric oxide suppresses human T lymphocyte proliferation through IFN-γ-dependent and IFN-γ-independent induction of apoptosis. J. Immunol. 1999. 163: 4182-4188.
36. Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R., Coffman, R. L., Hawrylowicz, C. M. and O'Garra, A., In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002. 195: 603-616.
37. Bzowska, M., Guzik, K., Barczyk, K., Ernst, M., Flad, H. D. and Pryjma, J., Increased IL-10 production during spontaneous apoptosis of monocytes. Eur. J. Immunol. 2002. 32: 2011-2020.
38. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M. and Taniguchi, M., Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 1997. 278: 1623-1626.
39. Mendiratta, S. K., Martin, W. D., Hong, S., Boesteanu, A., Joyce, S. and Van Kaer, L., CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997. 6: 469-477.
40. Osman, Y., Kawamura, T., Naito, T., Takeda, K., Van Kaer, L., Okumura, K. and Abo, T., Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur. J. Immunol. 2000. 30: 1919-1928.